Instituto Rosenbusch S.A. (ROSE) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.542x

Based on the latest financial reports, Instituto Rosenbusch S.A. (ROSE) has a cash flow conversion efficiency ratio of -1.542x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AR$811.18 Million ≈ $586.98K USD) by net assets (AR$-526.19 Million ≈ $-380.75K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Instituto Rosenbusch S.A. balance sheet independence to measure how much of total assets are equity-financed.

Instituto Rosenbusch S.A. - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Instituto Rosenbusch S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ROSE operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Instituto Rosenbusch S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Instituto Rosenbusch S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shin Hwa Silup KO:001770	-0.042x
Granada Gold Mine Inc V:GGM	0.002x
Blockmate Ventures Inc V:MATE	0.102x
Careteq Ltd AU:CTQ	-0.265x
Elkop SA WAR:EKP	0.043x
Bluelinea SA PA:ALBLU	-0.615x
Strategic Energy Resources Limited F:EB8	-0.012x
Akash Infra-Projects Limited NSE:AKASH	0.021x

Annual Cash Flow Conversion Efficiency for Instituto Rosenbusch S.A. (2000–2025)

The table below shows the annual cash flow conversion efficiency of Instituto Rosenbusch S.A. from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see ROSE stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AR$-526.19 Million ≈ $-380.75K	AR$409.89 Million ≈ $296.60K	-0.779x	-531.50%
2024-12-31	AR$3.99 Billion ≈ $2.89 Million	AR$720.31 Million ≈ $521.22K	0.181x	+147.75%
2023-12-31	AR$4.55 Billion ≈ $3.29 Million	AR$331.37 Million ≈ $239.78K	0.073x	-40.74%
2022-12-31	AR$400.51 Million ≈ $289.81K	AR$49.25 Million ≈ $35.64K	0.123x	-58.04%
2021-12-31	AR$199.19 Million ≈ $144.13K	AR$58.37 Million ≈ $42.24K	0.293x	-34.20%
2020-12-31	AR$147.69 Million ≈ $106.87K	AR$65.78 Million ≈ $47.60K	0.445x	-13.10%
2019-12-31	AR$115.52 Million ≈ $83.59K	AR$59.20 Million ≈ $42.84K	0.513x	+439.11%
2018-12-31	AR$145.95 Million ≈ $105.61K	AR$-22.06 Million ≈ $-15.96K	-0.151x	-272.55%
2017-12-31	AR$86.58 Million ≈ $62.65K	AR$-3.51 Million ≈ $-2.54K	-0.041x	-121.32%
2016-12-31	AR$83.24 Million ≈ $60.23K	AR$15.84 Million ≈ $11.46K	0.190x	+252.20%
2015-12-31	AR$70.62 Million ≈ $51.10K	AR$-8.83 Million ≈ $-6.39K	-0.125x	-192.60%
2014-12-31	AR$68.24 Million ≈ $49.38K	AR$9.21 Million ≈ $6.67K	0.135x	-32.36%
2011-12-31	AR$56.25 Million ≈ $40.70K	AR$11.23 Million ≈ $8.12K	0.200x	+96.02%
2010-12-31	AR$50.20 Million ≈ $36.32K	AR$5.11 Million ≈ $3.70K	0.102x	+352.72%
2009-12-31	AR$46.95 Million ≈ $33.97K	AR$1.06 Million ≈ $764.13	0.022x	-87.71%
2008-12-31	AR$45.65 Million ≈ $33.03K	AR$8.36 Million ≈ $6.05K	0.183x	+811.58%
2007-12-31	AR$37.50 Million ≈ $27.13K	AR$753.00K ≈ $544.87	0.020x	-65.96%
2006-12-31	AR$35.97 Million ≈ $26.03K	AR$2.12 Million ≈ $1.54K	0.059x	-61.58%
2005-12-31	AR$34.13 Million ≈ $24.70K	AR$5.24 Million ≈ $3.79K	0.154x	-9.98%
2003-12-31	AR$28.27 Million ≈ $20.45K	AR$4.82 Million ≈ $3.49K	0.171x	+122.37%
2002-12-31	AR$24.17 Million ≈ $17.49K	AR$1.85 Million ≈ $1.34K	0.077x	+268.10%
2000-12-31	AR$11.90 Million ≈ $8.61K	AR$248.00K ≈ $179.45	0.021x	--

About Instituto Rosenbusch S.A.

BA:ROSE Argentina Drug Manufacturers - Specialty & Generic

Market Cap

$4.93 Million

AR$6.81 Billion ARS

Market Cap Rank

#28612 Global

#77 in Argentina

Share Price

AR$160.00

Change (1 day)

+1.27%

52-Week Range

AR$119.50 - AR$327.00

All Time High

AR$380.00